Marzo 2023

ADVANCEMENT IN PERIODONTAL REGENERATION STUDY AWAITS FINAL APPROVAL

di assistenza@iplusservice.it

WhiteNest Pharma announces a pivotal moment in the quest for innovative periodontal treatments. Our latest project, focused on the use of lyophilized umbilical cord blood platelet lysate for periodontal regeneration, has been meticulously developed and is now poised for the… Leggi tutto »ADVANCEMENT IN PERIODONTAL REGENERATION STUDY AWAITS FINAL APPROVAL

NEW CNS CLARIFICATION ENHANCES ACCESS TO BIONEST 12D IN ITALY

di assistenza@iplusservice.it

WhiteNest Pharma announces a pivotal advancement for non-transfusional blood components in Italy, following the Centro Nazionale Sangue’s (CNS) recent clarification on national tariffs, as detailed in their FAQ section. This update directly impacts the use of adult blood allogenic platelets… Leggi tutto »NEW CNS CLARIFICATION ENHANCES ACCESS TO BIONEST 12D IN ITALY